Australia markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.49+0.82 (+3.07%)
At close: 04:00PM EDT
27.00 -0.49 (-1.78%)
Pre-market: 08:00AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts11111211
Avg. Estimate-1.04-1.05-2.56-2.93
Low estimate-1.27-1.3-4.17-3.79
High estimate-0.82-0.850.84-0.48
Year ago EPS-0.98-1.08-3.95-2.56
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts791010
Avg. Estimate3.57M5.73M370.2M186.4M
Low estimateN/AN/A211.12M116.1M
High estimate15M26.1M912.28M348.34M
Year ago salesN/A4.04M9.3M370.2M
Sales growth (year/est)N/A41.80%3,879.40%-49.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.83-0.82-0.91-0.71
Actual EPS-0.98-1.08-0.96-0.2
Difference-0.15-0.26-0.050.51
Surprise %-18.10%-31.70%-5.50%71.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.04-1.05-2.56-2.93
7 days ago-1.04-1.05-2.56-2.93
30 days ago-1.04-1.05-2.56-2.94
60 days ago-1.04-1.05-2.48-2.84
90 days ago-0.9-0.93-3.27-3.06
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBBIOIndustrySector(s)S&P 500
Current qtr.-6.10%N/AN/AN/A
Next qtr.2.80%N/AN/AN/A
Current year35.20%N/AN/AN/A
Next year-14.50%N/AN/AN/A
Next 5 years (per annum)67.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A